Trump’s Pharma Tariffs: Risks, Impact & Strategy

This is not a recent development; it started with the end of Trump’s first term. During the last quarter, executive orders were issued to cut down the costs of medicines. However, the federal court dismissed the motion, citing that this motion didn’t involve public opinion. The Biden administration also attempted it with the IRA when […]